Transforming drug discovery
Relay Therapeutics is a clinical-stage precision medicines company that integrates leading-edge computational and experimental technologies through its proprietary Dynamo Platform. The platform models protein motion to identify and drug previously intractable targets. Its pipeline is focused on precision oncology and genetic disease, with multiple programs in clinical development including collaborations with major pharma partners.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJul 2020
Dec 2018
Dec 2017
Sep 2016
Create a free account to see which investors have funded this company.
Create Free Account
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
